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SUMMARY
Cancer cells function as primary architects of the tumor microenvironment. However, the molecular features
of cancer cells that govern stromal cell phenotypes remain unclear. Here, we show that cancer-associated
fibroblast (CAF) heterogeneity is driven by lung adenocarcinoma (LUAD) cells at either end of the epithe-
lial-to-mesenchymal transition (EMT) spectrum. LUAD cells that have high expression of the EMT-activating
transcription factor ZEB1 reprogramCAFs through a ZEB1-dependent secretory program and direct CAFs to
the tips of invasive projections through a ZEB1-driven CAF repulsion process. The EMT, in turn, sensitizes
LUAD cells to pro-metastatic signals from CAFs. Thus, CAFs respond to contextual cues from LUAD cells
to promote metastasis.
INTRODUCTION
Accumulation of a densely fibrotic, immunosuppressive tumor
stroma facilitates metastasis and is correlated with a worse clin-
ical outcome in advanced epithelial malignancies (Kalluri, 2016;
Werb and Lu, 2015). Cancer-associated fibroblasts (CAFs) are
phenotypically heterogeneous mesenchymal cells that originate
from diverse cell types and are a major source of cytokines and
extracellular matrix molecules that enhance tumor cell-invasive
activity, recruit vasculature, and suppress anti-tumor immunity
(Gascard and Tlsty, 2016; Kalluri, 2016). In line with these
findings, single-cell RNA sequencing studies have identified
functional differences between CAFs and have shown that extra-
cellular matrix production and immunoregulatory functions
segregate to distinct CAF populations (Bartoschek et al., 2018;
Elyada et al., 2019). Pharmacologic and genetic approaches to
target CAFs in preclinical models result in widely disparate ef-
fects that range from tumor suppression to tumor promotion
(Feig et al., 2013; Kraman et al., 2010; Loeffler et al., 2006; Olive
et al., 2009; Özdemir et al., 2014; Provenzano et al., 2012; Su
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et al., 2018). Clearly, themolecular underpinnings of CAF hetero-
geneity must be better understood before CAF-targeting ap-
proaches can be tested in cancer patients.
There is a growing appreciation that cancer cells function as
primary architects of the tumor microenvironment (Li and
Stanger, 2019; Prager et al., 2019). Oncogenic mutations and
epigenetic events in cancer cells upregulate immunoregulatory
molecules and activate cytokine secretion, leading to the crea-
tion of an immunosuppressive milieu marked by the presence
of pro-tumorigenic lymphoid and myeloid cell populations and
reductions in anti-tumor CD8+ T cells (Li et al., 2018; Spranger
and Gajewski, 2018). Cancer stem cells, which have the capacity
to self-renew and undergo a reversible epithelial-to-mesen-
chymal transition (EMT), are capable of immune evasion and
creating and maintaining tumor-promoting myeloid and T cell
populations in the tumor microenvironment (Prager et al., 2019;
Zhou et al., 2015). In lung adenocarcinoma (LUAD) patients,
EMT features are correlated with advanced disease and worse
clinical outcome (Larsen et al., 2016). Based on this conceptual
framework, here, we postulated that contextual cues from LUAD
cells govern CAF heterogeneity.
RESULTS
CAF heterogeneity in LUAD
To test our hypothesis, we studied CAF heterogeneity in KrasLA1
mice, which develop LUAD from somatic activation of a latent
KrasG12D allele (Johnson et al., 2001). KrasLA1 mice harbor a
Thy-1+ CAF population (hereafter called tCAFs) that, in co-cul-
ture with KrasLA1-derived LUAD cells, generates a cytokine-
rich collagenous matrix and promotes LUAD cell invasion
(Pankova et al., 2016; Roybal et al., 2011). We isolated tCAFs
from KrasLA1 mice (Figure 1A) and subjected them to multiple
annealing and dC-tailing-based quantitative single-cell RNA
sequencing (MATQ-seq), a highly sensitive single-cell RNA-seq
assay (Sheng et al., 2017). After excluding non-fibroblastic cells
based on expression levels of cell-type-specific markers (Table
S1), we identified two distinct tCAF clusters (Figure 1B) that
were distinguishable based on 980 differentially expressed
genes (Table S2). Quality control metrics showed that clustering
was not related to batch-to-batch variability or sequencing
depth (Figure S1). By gene set enrichment analysis (GSEA), clus-
ter 1 was enriched in, among other terms, ‘‘EMT,’’ ‘‘inflammatory
response,’’ ‘‘hypoxia,’’ ‘‘glycolysis,’’ ‘‘myogenesis,’’ and ‘‘angio-
genesis’’ (Figure 1C). These terms are features of activated fibro-
blasts (Kalluri, 2016). In contrast, cluster 2 was enriched in
‘‘Notch signaling’’ and ‘‘PI3K/AKT/mTOR signaling’’ (Figure 1C).
Thus, tCAFs contained two distinct subpopulations.
To assess whether clusters 1 and 2 are generated by contex-
tual cues from LUADcells, we co-cultured tCAFswith LUAD cells
derived from KrasLA1;Trp53R172H mice (Gibbons et al., 2009).
These murine LUAD cell lines are positioned at either end of the
EMT spectrum and display variable metastatic properties (high
or low) following injection into syngeneic, immunocompetent
mice (Gibbons et al., 2009). Highly metastatic LUAD cell lines un-
dergo a reversible EMT through mutual antagonism between the
EMT-activating transcription factor zinc finger E-box binding ho-
meobox 1 (ZEB1) and microRNA-200 (miR-200) family members
(Ahnet al., 2012;Gibbonset al., 2009; Tanet al., 2017, 2018;Yang
et al., 2011). We generated 80-cell aggregates containing tCAFs
alone or tCAFs and LUAD cells (30:50 ratio) that are mesen-
chymal and highly metastatic (344SQ cells) or epithelial and
poorly metastatic (393P cells). After 48 h, tCAFs were isolated
from the multicellular aggregates by flow sorting and subjected
to bulk-cell RNA-seq (Figure 1D). tCAFs acquired distinct tran-
scriptomic features in co-culture with 344SQ cells or 393P cells
(Figure 1E; Table S2). A gene expression signature derived from
344SQ-co-cultured tCAFs was more highly correlated with clus-
ter 1 than cluster 2 (Figure 1F), whereas a gene expression signa-
ture derived from393P-co-cultured CAFswasmore highly corre-
latedwith cluster 2 than cluster 1 (Figure 1G). Thus, clusters 1 and
2weredistinguishablebasedonsignatures tCAFsacquired inco-
culture with LUAD cells at either end of the EMT spectrum.
LUAD cells at either end of the EMT spectrum govern
tCAF heterogeneity
Based on GSEA of upregulated genes, the terms ‘‘TGF-b
signaling,’’ ‘‘EMT,’’ ‘‘angiogenesis,’’ and ‘‘glycolysis’’ were
higher in co-cultured than mono-cultured tCAFs (Figures 2A,
left bar graph and S2A). Comparisons between tCAFs co-
cultured with 344SQ cells or 393P cells revealed sharp differ-
ences; among other terms, ‘‘hypoxia,’’ ‘‘interferon-g,’’ ‘‘TNF-a
signaling via NF-kB,’’ ‘‘IL-2 STAT5 signaling,’’ and ‘‘inflammatory
response’’ were higher in 344SQ-co-cultured tCAFs, whereas
‘‘angiogenesis,’’ ‘‘EMT,’’ ‘‘myogenesis,’’ ‘‘Notch signaling,’’ and
‘‘Wnt b-catenin signaling’’ were higher in 393P-co-cultured
tCAFs (Figure 2A, center bar graph), which led us to postulate
that the EMT state of LUAD cells influences the phenotypic prop-
erties of tCAFs. To test this hypothesis, we generated multicel-
lular aggregates containing tCAFs and 344SQ cells that have
been subjected to small hairpin RNA (shRNA)-mediated ZEB1
depletion, which induces a shift toward an epithelial state (Tan
et al., 2017), and found that GSEA hallmarks upregulated in
tCAFs co-cultured with ZEB1-deficient 344SQ cells overlap
with those upregulated in 393P-co-cultured tCAFs (Figure 2A,
center and right bar graphs), which supported our hypothesis.
In multicellular aggregates, cells can communicate through
direct contact or soluble factor exchange. Bothmeans of commu-
nication are thought to drive the outgrowth of myofibroblastic and
pro-inflammatoryCAFs inpancreatic cancer (Biffi et al., 2019;Dror
et al., 2016;Mitra et al., 2012). To address the role of soluble factor
exchange, we introduced tCAFs and LUAD cells (344SQ or 393P)
into Boyden chambers separated by a porous filter. Based on
bulk-cell RNA-seq, tCAFs acquired distinct transcriptomic fea-
tures in co-culture with 344SQ cells and 393P cells (Figures 2B
and S2B; Table S2). Concordance between the GSEA hallmarks
that tCAFs acquired inBoydenchambers (Figure2B) andmulticel-
lular aggregates (FigureS2A)washigher in tCAFs co-culturedwith
344SQ cells than 393P cells (55% versus 26%, respectively),
which suggests that soluble factor exchange played a more cen-
tral role in tCAF reprogrammingby344SQcells thanby393Pcells.
EMT sensitizes LUAD cells to pro-metastatic signals
from tCAFs
To assess how tCAF reprogramming influences LUAD progres-
sion, we generated orthotopic LUADs by intra-thoracic injection




of LUAD cells alone (344SQ or 393P, 106 per mouse) or in com-
bination with tCAFs (5 3 105 of each) into syngeneic, immuno-
competent mice (Figure 3A) and found that tCAFs enhanced
the metastatic activity of orthotopic tumors generated by
344SQ cells but not 393P cells (Figures 3B and 3C). Based on
measurements of primary tumor sizes (Figure 3B), tCAF-induced
metastatic activity was not related to increased 344SQ tumor
growth. To test the hypothesis that EMT sensitizes LUAD cells
to pro-metastatic signals from tCAFs, we repeated the experi-
ment on ZEB1-deficient 344SQ cells and found that tCAFs did
not enhance metastasis under those conditions (Figure 3D),
which supported our hypothesis.
High ZEB1 levels in LUAD cells drive the formation of
tCAF-led invasive structures
Notably, the co-injected tCAFs were present in regional lym-
phatics and distant metastatic deposits (Figures 3E and 3F),




Figure 1. LUAD cells shape tCAF heterogeneity
(A) tCAFs isolated by flow sorting from lung tissues in KrasLA1 mice were subjected to single-cell RNA sequencing.
(B) Principal-component analysis (PCA) plot of murine tCAFs (n = 428) subjected to single-cell RNA sequencing.
(C) GSEA of upregulated genes in tCAFs clusters. Normalized enrichment scores (NESs) represented by bar length. False discovery rate (FDR) values color-
coded.
(D) Multicellular aggregates generated in microwell plates were incubated for 48 h and subjected to flow sorting to isolate tCAFs for bulk-cell RNA sequencing.
n = 3 biological replicates per condition.
(E) PCA plot of tCAFs from triplicate multicellular aggregate preparations (dots) subjected to bulk-cell RNA sequencing.
(F and G) Correlations between single-cell RNA-sequencing data and expression signatures from tCAFs co-cultured with 344SQ cells (F) or 393P cells (G) are
depicted with correlation plots (left) and violin plots (right).




Figure 2. LUAD cells at either end of the EMT spectrum shape tCAF heterogeneity
(A) GSEA of upregulated genes in tCAFs that were mono- or co-cultured (left), co-cultured with 344SQ cells or 393P cells (center), or co-cultured with ZEB1-
deficient (shZEB1) or ZEB1-replete (control shRNA [shCTL]) 344SQ cells (right) in multicellular aggregates. NES represented by bar length. FDR values color-
coded. Hallmarks shared between co-cultures are indicated (asterisks).
(B) PCA plot of tCAFs from Boyden chamber preparations (dots) subjected to bulk-cell RNA sequencing. GSEA of upregulated genes in tCAFs that were mono-
cultured (mono-) or co-cultured (co-) with 393P cells or 344SQ cells in Boyden chambers. NES represented by bar length. FDR values color-coded. n = 5
biological replicates per condition.




capacity to generate organized, invasive structures. To examine
this possibility, we performed live-cell imaging on multicellular
aggregates in 3-dimensional (3D) collagen gels (Figure 4A) and
identified invasive projections containing a leading tCAF and
LUAD cells following collectively behind (Figure 4B; Video S1).
By time course studies, tCAF-led invasive structure formation
was initiated by a tCAF that migrated radially to the aggregate
periphery, exited the aggregate, and was followed by a LUAD
cell that maintained contact with the leading tCAF (Figure 4C;
Video S2). Treatment with a matrix metalloproteinase inhibitor
at a dose that does not inhibit cell proliferation (Figure S3)
reduced the numbers of invasive projections (Figure 4D), sug-
gesting that invasion required proteolytic activity. These findings
recapitulate features of ‘‘leader-follower’’ structures reported by
Gaggioli et al. (2007). tCAF-led invasive projections were signif-
icantly more numerous in aggregates containing mesenchymal
Figure 3. EMT sensitizes LUAD cells to pro-metastatic signals from tCAFs
(A) Orthotopic LUADs generated by intra-thoracic injection of LUAD cells alone or in combination with tCAFs in syngeneic, immunocompetent mice. Arrows point
to sites of primary tumor and mediastinal lymph node metastasis. Scale bar, 4 mm.
(B–D) Primary tumor diameters and numbers of contralateral lung metastases per mouse (dots) injected with 344SQ cells (B), 393P cells (C), or ZEB1-deficient
(shZEB1) or ZEB1-replete (shCTL) 344SQ cells (D) alone () or in combination with tCAFs (+). n = at least 8 mice per condition. p values, 2-sided t test, 1-way
ANOVA test.
(E) Merged fluorescence micrographs of fluorescently tagged 344SQ cells (red) and tCAFs (green) in primary tumor and metastases to contralateral lung,
mediastinal nodes, and kidney. Intact tissues imaged immediately after resection. Scale bars, 500 mm. n = 2 mice.
(F) Micrographs of primary tumor and metastases to contralateral lung and mediastinal nodes in a mouse co-injected with fluorescently tagged 344SQ cells and
tCAFs. Boxed regions are shown at higher magnifications (insets). Consecutive sections stained with hematoxylin and eosin or fluorescently tagged anti-GFP
antibody (a-GFP) to identify co-injected tCAFs (arrows). Nuclei counterstained with DAPI (blue). Scale bars, 4 mm (central image), 500 mm (fluorescent micro-
graphs). n = 2 mice.




than epithelial LUAD cell lines (Figure 4E). In gain- and loss-of-
function studies, ZEB1 enhanced tCAF-led invasive structure
formation (Figures 4F and 4G). Based on reports that ZEB1 pro-
motes LUAD metastasis by relieving key mediators from miR-
dependent silencing (Ahn et al., 2012; Gibbons et al., 2009;
Tan et al., 2017, 2018; Yang et al., 2011), we ectopically ex-
pressed ZEB1-silenced miRs (miR-200, miR-206, miR-148a, or
miR-181) in 344SQ cells and found that the numbers of tCAF-
led invasive structures sharply decreased (Figure 4H). Thus,
miR silencing in LUAD cells plays a key role in tCAF-led invasive
structure formation.
LUAD cells repel tCAFs through a ZEB1-driven
secretory process
To assess the importance of tCAF motility in invasive structure
formation, we subjected tCAFs to small interfering RNA
(siRNA)-mediated depletion of the DDR2 collagen receptor (Fig-
ure 5A), which promotes CAF motility (Bayer et al., 2019), and
found that tCAF migration to the aggregate periphery and
tCAF-led invasive structure formation were reduced (Figures
5B and 5C). To determine whether tCAF motility was related to
the EMT state of LUAD cells, we quantified radial tCAF move-
ment in aggregates containing LUAD cells at either end of the
EMT spectrum and found that movement was greater in aggre-
gates containing mesenchymal than epithelial LUAD cells (Fig-
ures 5D and 5E; Video S3) and was impaired by shRNA-medi-
ated ZEB1 depletion in 344SQ cells (Figure 5F). To determine
whether high ZEB1 expression causes LUAD cells to repel
tCAFs, we assessed the ability of tCAFs and LUAD cells to mix
across a scratch wound and found that tCAFs mixed to a greater
extent with epithelial than mesenchymal LUAD cells (Figure 6A;
Videos S4 and S5). In gain- and loss-of-function studies, ZEB1
impaired LUAD cell mixing with tCAFs (Figures 6B and 6C).
Cancer cells secrete cytokines and extracellular matrix mole-
cules that can attract or repulse cells in the tumor microenviron-
ment (Lu et al., 2012). To identify factors secreted by 344SQ cells
that mediate tCAF repulsion, we performed liquid chromatog-
raphy-mass spectrometry on conditioned medium samples
isolated from LUAD cells (344SQ or 393P) and tCAFs in mono-
culture or co-culture. Of the 1,296 total proteins identified,
numerous collagens, matricellular proteins, and proteases
were present at higher levels in 344SQ cells (Figure S4), including
inter-alpha-trypsin inhibitor heavy chain 2 (ITIH2), a secreted
protein that stabilizes hyaluronan, which reduces the elasticity
of tumor tissue and increases interstitial fluid pressure (Whatcott
et al., 2011). ITIH2 mRNA levels were higher in 344SQ cells than
393P cells and were upregulated by ectopic ZEB1 expression in
393P cells (Figure 6D). tCAFs mixed to a greater extent with
ITIH2-deficient than ITIH2-replete 344SQ cells (Figures 6E and
6F), which suggests that LUAD cells repel tCAFs through a
ZEB1-dependent secretory process.
DISCUSSION
Metastasis requires a high degree of tumor cell plasticity asman-
ifested by the capacity to switch between migratory modes,
evade immune surveillance, andmaintain viability under stressful
conditions (Egeblad et al., 2010; Odenthal et al., 2016). In one
working hypothesis, EMT confers the invasive and stem-ness
properties necessary for cancer cells to dissolve junctional com-
plexes, intravasate into vascular structures, and colonize the
metastatic niche (Chockley and Keshamouni, 2016; Krebs
Figure 4. ZEB1 drives tCAF-led invasive
structure formation
(A) Multicellular aggregates generated in microwell
plates were transferred to collagen gels for imaging
of invasive structure formation.
(B) Confocal micrograph of amulticellular aggregate
containing tCAF-led invasive structures (arrows).
Scale bar, 100 mm.
(C) Montage of confocal micrographs from live-cell
imaging of a multicellular aggregate. tCAF (green),
344SQ cells (magenta). Scale bars, 15 mm.
(D) Percentage of aggregates that develop invasive
projections in the presence or absence of protease
inhibitor GM6001 (20 mM). n = at least 25 aggregates
per condition. p values, Fisher’s exact test.
(E) Percentages of total projections led by tCAFs per
multicellular aggregate (dots). n = at least 6 aggre-
gates per cell line. Epithelial (E) or mesenchymal (M)
LUAD cell lines. p values, 2-sided t test.
(F–H) Percentages of total projections led by tCAFs
per multicellular aggregate (dots). 393P cells stably
transfected with ZEB1 (+) or empty vector (). n = at
least 13 aggregates per condition (F). 344SQ cells
stably transfected with ZEB1 shRNA (+) or scram-
bled control shRNA (). n = at least 7 aggregates per
condition. (G) 344SQ cells stably transfected with
miRs or empty vector (). (H) n = at least 11 ag-
gregates per condition.
p values, 2-sided t test, 1-way ANOVA test.
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et al., 2017; Puisieux et al., 2014). The findings presented here
support a paradigm that incorporates the tumor microenviron-
ment into the regulatory network of EMT-activating transcription
factors and a model in which cancer cells reside at the apex of a
signaling hierarchy in the tumor microenvironment (Li and
Stanger, 2019).
Reports on CAF heterogeneity have primarily used droplet-
based single-cell RNA-seq technologies to interrogate large
numbers of fibroblastic cells (Lambrechts et al., 2018). Here,
we used a highly sensitive RNA sequencing platform to explore
heterogeneity within an immunophenotypically defined (Thy-1+)
CAF population. To deconvolve tCAF complexity, we probed
single-cell RNA-seq data with expression signatures identified
in co-cultured and mono-cultured tCAFs and found that tCAFs
could be distinguished based on these signatures. Thus,
comparative studies on defined CAF populations are feasible
in the context of a highly sensitive single-cell RNA-seq method,
and insight into the molecular underpinnings of tCAF complexity
provided the reaction coordinates needed for complexity
deconvolution.
The viability of circulating cancer cells is higher if they are
incorporated into stromal fragments that provide an early growth
advantage to cancer cells in the metastatic niche, which is the
basis for the current belief that cancer cells bring their own
‘‘soil’’ to the metastatic niche (Duda et al., 2010). We found
that tCAFs localized in the metastatic niche and generated
tCAF-led invasive structures in response to ZEB1-driven repul-
sive forces from LUADcells (Figure 6F), which builds on evidence
that CAF-led invasive structures are stabilized by mechanically
active heterotypic contacts that generate force and enable inva-
sion (Labernadie et al., 2017). In line with our findings, EMT acti-
vates contact inhibition of locomotion to guide cell migration dur-
ing embryonic development (Scarpa et al., 2015; Stramer and
Mayor, 2017).
Collagen fibers secreted by CAFs create a stiff, fibrotic tumor
stroma that promotes cancer cell invasion (Bayer et al., 2019;
Corsa et al., 2016; Erdogan et al., 2017; Yamauchi et al.,
2018). Selective antagonists of DDR2 and collagen-binding in-
tegrins (a1b1, a2b1, a10b1, a11b1) inhibit the pro-metastatic ac-
tivity of CAFs (Grither and Longmore, 2018; Raab-Westphal
et al., 2017). Based on the findings presented here, clinical trials
designed to inhibit CAF motility through the use of selective
inhibitors of collagen receptors are warranted as part of the
ongoing efforts to develop CAF-targeting therapies (Kalluri,
2016; LeBleu and Kalluri, 2018).
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Figure 6. LUAD cells repel tCAFs through a ZEB1-driven secretory program
(A) Micrographs (far-left panels) of the leading front of a scratch wound containing tCAFs (green) and LUAD cells (red). Masks generated for each channel (2nd and
3rd panels) were overlaid (far-right panels). Scale bar, 100 mm. Mixing was quantified based on the overlapping area per field (dots) in scratch wounds containing
epithelial (E) or mesenchymal (M) LUAD cell lines (color-coded). n = 3 biological replicates per cell line. p values, 2-sided t test.
(B and C) Mixing quantified in scratch wound assays containing tCAFs and 393P cells stably transfected with ZEB1 (+) or empty vector () (B) or 344SQ cells
transfected with shZEB1 (+) or scrambled shRNA () (C). n = 3 biological replicates per condition. p values, 2-sided t test, 1-way ANOVA test.
(legend continued on next page)
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Antibodies
Anti-GFP Novus Biologicals Cat# NB600-308; RRID:AB_10003058
Anti-Itih2 Novus Biologicals Cat# NBP2-31750
Anti-b-Actin Cell Signaling Technology Clone 13E5, Cat# 4970; RRID:AB_2223172
PE anti-mouse CD45 Biolegend Cat# 103106; RRID:AB_312971
PE Rat IgG2a, k Isotype Ctrl Biolegend Cat# 400508; RRID:AB_326530
PE anti-mouse CD31 Biolegend Cat# 102508; RRID:AB_312915
PE Rat IgG2b, kappa Isotype Ctrl Biolegend Cat# 400608; RRID:AB_326552
Alexa Fluor 488 anti-mouse CD326 (Ep-CAM) Biolegend Cat# 118210; RRID:AB_1134099
Alexa Fluor 488 Rat IgG2a, k Isotype Ctrl Biolegend Clone RTK2758; Cat# 400525
PE/Cy7 anti-mouse Ly-6A/E (Sca-1) Biolegend Cat# 108114; RRID:AB_493596
PE/Cy7 Rat IgG2a, k Isotype Ctrl Biolegend Cat# 400522; RRID:AB_326542
CD90 / Thy1 antibody [G7] Abcam Cat# ab25322; RRID:AB_470438
Rat IgG2b kappa Isotype Control (eB149/10H5),
APC-eFluor 780
Thermo Fisher Scientific Cat# 47-4031-80; RRID:AB_1272021
Anti-rabbit IgG, HRP-linked Antibody Cell Signaling Technology Cat# 7074; RRID: AB_2099233
Donkey anti-Rabbit IgG (H+L) Highly Cross-Adsorbed
Secondary Antibody, Alexa Fluor 568
Thermo Fisher Scientific Cat# A10042; RRID:AB_2534017
Alexa Fluor 568 Phalloidin Thermo Fischer Scientific Cat# A12380
Bacterial and virus strains
Bacteria: Subcloning Efficiency DH5a Competent Cells Thermo Fischer Scientific Cat# 18265017
Biological samples
Human Lung Adenocarcinoma tissue UT MD Anderson Cancer Center N/A
Human IPF tissue The University of California
San Francisco
N/A
Chemicals, peptides, and recombinant proteins
DAPI Thermo Fischer Scientific Cat# R37606
Collagenase type I (CLSS-1 filtered) Worthington Biochemical Cat# LS004216
Dispase II Roche Cat# 04942078001
RBC buffer Biolegend Cat# 420301
Puromycin InvivoGene Cat#ant-pr
Blasticidin InvivoGene Cat# ant-bl-1
Matrigel Corning Cat# 356231
CellTracker Deep Red Dye Fisher Scientific Cat# C34565
Collagen R solution 0.4% Serva Cat# 47256.01
Protease inhibitor GM6001 MD Millipore Cat# 364206-1MG
paraformaldehyde Electron Microscopy Sciences Cat# 15714-S
JetPRIME transfection reagent Polyplus Cat# 114-15
Pluronic F-127 Sigma-Aldrich Cat# p2443-250G
PCR-grade mineral oil Sigma-Aldrich Cat# No. M8662
RnaseOUT Thermo Fischer Scientific Cat# 10777019
Superscript III Thermo Fischer Scientific Cat# 18080093
Bst 2.0 WarmStart DNA Polymerase NEB Cat# M0538S
(Continued on next page)





REAGENT or RESOURCE SOURCE IDENTIFIER
AMPure XP beads Beckman Coulter Cat#. A63880
Duplex-specific Nuclease Evrogen Cat# EA003
KAPA HIFI Hotstart Ready Mix KAPA Biosystem Cat# KK2601
Critical commercial assays
RNeasy Mini Kit QIAGEN Cat# 74106
qScript cDNA SuperMix QuantaBio Cat# 101414-106
WST-1 Takara Cat# MK400
SuperSignal West Femto Maximum Sensitivity Substrate Thermo Fischer Scientific Cat# 34096
Nextera DNA library prep kit Illumina Cat# FC-121-1030
NextSeq 500/550 High Output Kit v2.5 (150 Cycles) Illumina Cat# 20024907
NextSeq 500/550 Mid Output Kit v2.5 (150 Cycles) Illumina Cat# 20024904
NEBNext Poly(A) mRNA Magnetic Isolation Module NEB Cat# E7490
NEBNext Ultra II RNA library Prep Kit NEB Cat# E7770
Deposited data
Raw and analyzed data This paper GEO: GSE166480
NCBI Gene Expression Omnibus database Tian et al., 2020 GEO: GSE136904
Mouse reference genome NCBI build 38, mm10 Genome Reference Consortium https://www.ncbi.nlm.nih.gov/grc/mouse
Experimental models: cell lines
Mouse: 344SQ, 393P, 531LN1, 531LN2, 307P, 412P,
and their transfected derivatives
Gibbons et al., 2009 N/A
Mouse: 344SQ_RFP Padhye et al., 2019 N/A
Mouse: 344SQ_shCtL, 344SQ_shZEB1, 344SQ_mir206,
344SQ_mir148a
Tan et al., 2017 N/A
Mouse: 393P_vec, 393P_ZEB1, 344SQ_miR-181 Tan et al., 2018 N/A
Mouse: 344SQ_miR-200 Ahn et al., 2012 N/A
Mouse: CAFS-GFP This paper N/A
Mouse: 393_RFP This paper N/A
Experimental models: organisms/strains
Mouse: KrasLA1/+, 129/SV The Jackson Laboratory N/A
Oligonucleotides
siRNA against murine DDR2 Sigma-Aldrich SASI_Mm01_00106702
siRNA against murine DDR2 Sigma-Aldrich SASI_Mm01_00106703
siRNA against murine DDR2 Sigma-Aldrich SASI_Mm01_00106704
siRNA against murine Itih2 Sigma-Aldrich SASI_Mm01_00067716
siRNA against murine Itih2 Sigma-Aldrich SASI_Mm01_00067717
siRNA against murine Itih2 Sigma-Aldrich SASI_Mm01_00067718
Universal siRNA negative control #2 Sigma-Aldrich N/A
DDR2_F: TCATCCTGTGGAGGCAGTTCTG Sigma-Aldrich N/A
DDR2_R: CTGTTCACTTGGTGATGAGGAGC Sigma-Aldrich N/A
RLP32_F: GGAGAAGGTTCAAGGGCCAG Sigma-Aldrich N/A
RLP32_R: TGCTC CCATAACCGATGTTTG Sigma-Aldrich N/A
Itih2_F: ACCAGGACACATCCTCTCAGCT Sigma-Aldrich N/A
Itih2_R: CAGAACCTCCGAAGTAGTTGTGG Sigma-Aldrich N/A
MATQ-seq primer mix Sheng et al., 2017 N/A
Recombinant DNA
pLVX-puro Clontech Cat# 632164
EF-pLenti6.3-GFP Dr. Scott lab (BCM) N/A
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Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Jonathan
M. Kurie (jkurie@mdanderson.org)
Materials availability
Mouse lines generated during this study are completely available upon request to the Lead Contact.
Data and code availability
The raw data of single cell RNA-seq andmini-bulk RNA-seq have been submitted to GEO: GSE166480. Sequencing depth andmap-
ping can be found in Table S1.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animal husbandry and in vivo experiments
All mouse studies were approved by the Institutional Animal Care and Use Committee at The University of Texas MD Anderson Can-
cer Center. Mice received standard care and were euthanized according to the standards set forth by the Institutional Animal Care
and Use Committee. To generate orthotopic lung tumors, 2-4 months old male littermates were randomly assigned to experimental
groups. An incision was made in syngeneic, immunocompetent mice between the 2nd and 3rd ribs on the left side. Cells were directly
injected into the left lung, and the wound was sutured. LUAD cells (RFP-tagged 344SQ, RFP-tagged 393P, 344SQ_shCTL or
344SQ_shZEB1) were injected alone (106 cells) or in combination with GFP-tagged tCAFs (5x105 of each cell type). Tissues were
formalin-fixed and paraffin-embedded for histologic confirmation of tumor cells by hematoxylin and eosin staining and fluorescent
antibody staining. Investigators were blinded to sample identities during analysis.
Cell lines
LUAD cells generated from KrasLA1/+;Tp53R172H/+ male mice (344SQ, 393P, 531LN1, 531LN2, 307P, 412P, and their transfected de-
rivatives) (Gibbons et al., 2009) were cultured in RPMI 1640 containing 10%FBS. Cells weremaintained at 37C in an incubator with a
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Software and algorithms
ImageJ Schneider et al., 2012 https://imagej.nih.gov/ij/
GraphPad Prism 7.03 GraphPad N/A
BD FACSDiva 6.1.3 software BD Biosciences N/A
NIS-Elements Nikon N/A
R Studio R studio https://www.r-project.org/
GSEA 4.0.3 Subramanian et al., 2005 https://www.gsea-msigdb.org/gsea/index.jsp
MATLAB R2019a The MathWorks, Inc. https://www.mathworks.com/products/
matlab.html
Cutadapt 1.18 Martin, 2011 https://github.com/marcelm/cutadapt/
STAR 2.5.3a Dobin et al., 2013 https://github.com/alexdobin/STAR
Samtools 1.7 Li et al., 2009 https://github.com/samtools/
htseq-count 0.10.0 Anders et al., 2015 https://pypi.org/project/HTSeq/
seqtk 1.2-r94 Shen et al., 2016 https://github.com/lh3/seqtk
gencode.vM10.annotation.gtf N/A https://www.gencodegenes.org/mouse/
release_M10.html
edgeR 3.26.8 Robinson et al., 2010 https://bioconductor.org/packages/release/
bioc/html/edgeR.html
Other
Transwell Boyden chambers Thermo Scientific Cat# 141078
Glass-bottom 35mm dishes Mattek Cat# P35G-1.5-14-C
Glass bottom 24-well plate Mattek Cat# P24G-1.5-13-F
Culture-insert 2-well, 35 mm plate Ibidi Cat# 81176




humidified atmosphere containing 5% CO2. Cells were passaged every 2-3 days or when they reached 80% confluence. tCAFs iso-
lated from KrasLA1 male mice were cultured in DMEMwith 10% FBS, 1% Pyruvate, and 1% Penicillin-Streptomycin, were passaged
every 3-5 days or upon reaching 75% confluence, and were used for a maximum of 5 passages after thawing. All co-culture exper-
iments and paired mono-culture controls were performed using amix of both cell culture mediums, at a 1:1 ratio. 393_RFP cells were
generated using the vector pLVX_mCherry (puromycin selection); the mCherry coding sequence was amplified by PCR and inserted
into a pLVX-puro vector (Clontech, Cat#632164). GFP-transfected tCAFs were generated with the vector EF-pLenti6.3-GFP (Blas-
ticidin selection). The remaining stably transfected cells are described elsewhere: 344SQ_RFP (Padhye et al., 2019); 344SQ_shCtL,
344SQ_shZEB1, 344SQ_mir206, 344SQ_mir148a (Tan et al., 2017); 393P_vec, 393P_ZEB1, 344SQ_miR-181 (Tan et al., 2018), and
344SQ_miR-200 (Ahn et al., 2012). For co-cultureco-culture experiments, 50,000 tCAFs were seeded into the bottom chamber of a
0.4mm Boyden chamber with or without 80,000 LUAD cells in the upper chamber. After 48h, tCAFs were collected from the bottom
chamber and subjected to RNA extraction. For transient transfection, cells were transfected with jetPRIME (Polyplus, Cat#114-15)
transfection reagent following the manufacturer’s suggested protocol.
METHOD DETAILS
Cell proliferation
Viable cell densities were quantified in sub-confluent monolayer culture conditions using water-soluble tetrazolium salt-1 (WST-1,
Takara Cat#MK400) reagent as suggested by manufacturer’s instructions (Takara).
Fibroblast isolation for single-cell RNA sequencing analysis
To obtain fresh fibroblasts for single cell RNA-seq, we resected whole lung tissues from age-matched (10-12 months-old) KrasLA1
mice (for tCAF isolation). The lungs were immediately perfused with 2% FBS in Hank buffered salt solution (FBS-HBSS) and
dispersed into single-cell suspensions by immersion in 3 mg/mL of collagenase (Worthington Biochemical; Cat#LS004216) and Dis-
pase II (Roche; Cat#04942078001) on a gentleMACS Dissociator (miltenyibiotec; Cat# 130-093-235) using the lung tissue dissoci-
ation programs (Lung_01 and Lung_02). Dispersed cells were filtered (70 mm and 40 mm), centrifuged, washed with FBS-HBSS,
and subjected to red blood cell lysis by adding RBC buffer (Biolegend; Cat#420301). The remaining cells were centrifuged, washed,
and counted. To isolate immunophenotypically defined tCAF populations (Thy-1+ Epcam- CD45- Sca-1- CD31-) (Roybal et al., 2011),
cells were stained for 45min on ice simultaneously with anti-Epcam-FITC (Biolegend; Cat#118210), anti-CD31-PE (Biolegend;
Cat#102508), anti-CD45-PE (Biolegend; Cat# 103106), anti-Sca-1-PECy7 (Biolegend; Cat#108114), and anti-Thy1-APC (Abcam;
Cat# ab25322). Control tubes containing 1x105 cells were stained with single antibodies or no antibody. Cells were subjected to
flow cytometry (FACSAriaII instrument, BD FACSDiva 6.1.3 software) using a 75mm nozzle. Cells were gated with the following
scheme: cells, singlets, live cells, negative for: FITC (EpCam), PE (CD31 and CD45), and PECy7 (sca-1), and positive for APC
(Thy1). Live/dead marker (DAPI; Thermo Fischer Scientific; Cat#R37606 was added, and only live cells were placed individually in
wells on a 96-well plate. The 96-well plate was kept at 4C before and during sorting and contained the first enzymes of the RNA
isolation protocol to minimize RNA degradation. Immediately after sorting, the plate was centrifuged for 30 s to mix the cells and en-
zymes. The remaining steps of the RNA sequencing protocol are described below.
RNA sequencing
We used a Bravo Automated Liquid Handler to robotically performMATQ-seq analysis (Sheng et al., 2017). To prevent evaporation
during the reactions, we first added 10 mL of PCR-grade mineral oil (Sigma, Cat. No. M8662) to every well of a 96-well plate (Bio-rad,
Cat. No. HSS9601). For cell lysis, 1 mL of lysis buffer containing 0.65 mL of 0.2%Triton X-100 ultrapure water (Thermo Fisher Scientific,
10777019), 0.2 mL of MATQ-seq primer mix (Sheng et al., 2017), 0.05 mL of dNTP (10mM each), 0.05 mL 0.1M DTT, and 0.05 mL
RnaseOUT (Thermo Fisher Scientific, Cat. No. 10777019) were premixed and then added to each well using the Liquid Handler.
The cell lysis plate was then briefly centrifuged. Individual tCAFs were flow sorted into 96-well plates. We lysed the cells with a
3-min incubation at 72C on a 96-well PCR machine and then quickly transferred the plate to ice for 1 min. We then added 1 mL
of reverse transcription mix containing 0.4 mL 5X FS buffer, 0.1 mL 0.1 M DTT, 0.05 mL RnaseOUT, 0.05 mL Superscript III (Thermo
Fisher Scientific, Cat. No. 18080093), and 0.4 mL RNase-free H2O to each well of the plate using the Liquid Handler. We performed
all the following steps of MATQ-seq using the robot and a 96-well PCR machine for temperature ramping according to the protocol
previously described (Sheng et al., 2017) with minor changes in enzyme amount. We also redesigned the second strand primer to
create a 3-basemismatch at the 30 end of the primer for later library preparation. For mini-bulk cell RNA sequencing analysis of tCAFs
isolated from multicellular aggregates, we used MATQ-seq as previously described (Sheng et al., 2017). As a quality control step,
mapping rates from single-cell and bulk RNA sequencing were quantified (Table S1).
To prepare libraries, we diluted 20 ng of amplified product into 10 mL for each cell. Samples were heated to 95C for 30 s to dena-
ture the cDNA. We then added double strand conversion mix containing 0.6 mL 10 mM barcoded primer, 2 mL 10X Thermopol Buffer,
0.5 mL 10mMeach dNTP, 0.3 mLBst 2.0WarmStartDNAPolymerase (NEB, Cat. No. M0538S), and 6.6 mL PCR grade water to each
sample. Twenty cycles of 60C 20 s, 65C 30 s were performed to convert the cDNA into double strand and to add Illumina adaptor
and barcode to the samples. 5 mL of 50mM EDTA was then added to each sample. We then pooled the samples into a single tube or
several tubes according to the assigned barcode. Pooled libraries were purified with 1.2x AMPure XP beads (Beckman Coulter, Cat.




No. A63880) into 20 mL of water. We then used the Nextera DNA library prep kit (Illumina, Cat. No. FC-121-1030) to tag 50 ng of the
libraries according to the protocol provided with the kit. We purified the tagged libraries with 1.2x AMPure XP beads. We then ampli-
fied the libraries according to the Nextera protocol using Illumina sequencing adapters. A size selection was then performed using
AMPure XP beads to select cDNA ranging from 250bp to 600 bp. We removed themajority of the ribosomal cDNAwith a treatment of
Duplex-specific Nuclease (Evrogen, Cat. No. EA003) using 100 ng of the library. We then purified the library using 0.9x AMPure XP
and amplified the library using KAPA HIFI Hotstart Ready Mix (KAPA Biosystem, Cat. No. KK2601). Libraries were then diluted and
sequenced on aNextseq 500machine, using the NextSeq 500/550 High Output Kit v2.5 (150 Cycles) or NextSeq 500/550Mid Output
Kit v2.5 (150 Cycles) (Illumina, Cat. No. 20024907 and 20024904).
Multicellular aggregates
Multicellular aggregates were created in a 24-well plate containing 1700 laser-ablated microwells per well as described (Albritton
et al., 2016). The microwells were passivated with 0.05% pluronic acid (Sigma-Aldrich; Cat#p2443-250G) for 1 h prior to seeding
the cells. For invasion assays in collagen gels, 85,000 LUAD cells alone or in combination with 51,000 tCAFs were seeded per
well and cultured for 48 h to generate aggregates, each containing 50 LUAD cells alone or 50 LUAD cells and 30 tCAFs. tCAFs
used to generate the aggregates originated from a common pool. Aggregates were mixed with rat tail collagen I (Collagen R solution
0.4%, Serva; Cat#47256.01) to generate collagen gels with defined concentrations (2mg/ml), volumes (200ml/gel), and aggregate
densities (35 aggregates/ gel). The gels were allowed to polymerize upside-down on a glass-bottom 35mm plate (Mattek;
Cat#P35G-1.5-14-C) or a glass-bottom 24-well plate (Mattek; Cat#P24G-1.5-13-F) at 37C for 30min. The aggregates were cultured
for up to 5 days. For protease activity inhibition, aggregates were treatedwith GM6001 (20mM,MDMillipore; Cat#364206-1MG) in the
collagen gel, for 3 days. Aggregates were fixed with 4% paraformaldehyde (Electron Microscopy Sciences; 15714-S) for 20 min at
room temperature (RT) for confocal microscopy. For bulk-RNA sequencing studies, GFP-tagged tCAFs were isolated from multicel-
lular aggregates (cultured for 48h) by disrupting the aggregates using a 301/2 gauge needle and isolating the tCAFs by flow sorting in
the green channel (FACSAriaII instrument, BD FACSDiva 6.1.3 software) using a 75mm nozzle. Live/dead marker (DAPI, Thermo
Fischer Scientific; Cat#R37606) was added. Live cells (at least 500 per replicate) were selected and subjected to RNA extraction pro-
tocol described elsewhere in this methods section.
Liquid chromatography-mass spectrometry of conditioned medium samples
For proteomic studies, conditioned medium samples were collected from microwells containing multicellular aggregates that had
been in culture for 48 h. After collection, the conditioned medium samples were filtered, concentrated, and analyzed as previously
described (Tan et al., 2020).
Microscopy
Images of fixed multicellular aggregates in 3D collagen gels were acquired with a NikonA1 confocal microscope, 10x objective. After
collecting z-slices, the volume was rendered into 2-dimensional projections by maximum intensity projection algorithm (ImageJ;
Schneider et al., 2012), and invasive structures were analyzed. An invasive projection was defined as at least one visible LUAD
cell protruding out of the aggregate. A tCAF-led invasive structure was defined as a projection containing at least 1 tCAF at the
tip. Invasive projections were manually counted. Results were determined from at least 10 multicellular aggregates per condition,
at least two collagens gels per condition, and at least two independent batches of aggregates. When possible, investigators were
blinded to sample identity when performing these quantifications.
Live-cell imaging was performed in an automated wide-field microscope (Nikon Eclipse TiE) with 20x objective. For 3-dimensional
image stacks, Z stacks were projected by using a sum of the slices algorithm. Invasive projections were identified after thresholding
to remove aggregate bodies (ImageJ). Diameters were measured after thresholding (ImageJ) to remove invasive projections from
the live-cell images. Results were determined from at least 3 aggregates per condition, at least two gels per condition, and two in-
dependent batches of aggregates.
Cell-cell repulsion
Multicellular aggregates were generated, transferred to collagen gels, and subjected to time-lapse movies. Fluorescence intensity in
the center of the aggregate was measured at initial (T = 0) and final (T = 4d) time points by performing radial profile analysis (ImageJ)
on tCAFs in the green channel. Results represent values from at least 3 biological replicates per condition. For scratch-wound closure
assays, 15,000 LUAD cells and 6,000 tCAFs were seeded on either side of a 35 mm culture-2-well insert glass-bottom dish (Ibidi;
Cat#81176). tCAFs and LUAD cells were distinguishable on the basis of fluorescent tags that included GFP in tCAFs and RFP or
CellTracker deep red dye (Fisher Scientific; Cat#C34565) in LUAD cells. Cells were stained with CellTracker dye for 30 min at RT
at a concentration of 1.5mM prior to seeding. The cells were allowed to reach confluence in each chamber, at which time the insert
was lifted to initiate cell migration and wound closure. Cells were imaged when the insert was lifted (initial time point, T = 0) and at the
final time point (T = 4 d) using a confocal microscope (NikonA1, 10x objective). Leading edges of the migrating cells were imaged and
analyzed for area of overlap using ImageJ. In brief, 16-bit raw images were converted to 8-bit, and a mask was generated for each
channel, which comprised the total area of each cell type. The two channels were overlaid and converted to RGB. The overlapping




area was measured and adjusted for the initial area of the chamber as described (Carmona-Fontaine et al., 2008). Results represent
values from at least 4 images per replicate, 3 biological replicates per condition.
To quantify extrusion of DDR2-deficient and –replete tCAFs from multicellular aggregates, we quantified GFP outside and inside
each aggregate body and used those values to calculate a ratio (outside/inside GFP area). For this purpose, z stack images of para-
formaldehyde-fixed aggregates in collagen gels were acquired by confocal microscopy (10X objective). Z stacks were rendered into
2-dimensional images by using a maximum intensity projection algorithm (ImageJ), converted to 8-bit, thresholded, and segmented
to generate masks of red and green channels, which were used to quantify LUAD cells and tCAFs, respectively, in the aggregate
body. GFP areas within and outside the aggregate body mask were determined.
tCAF detection in distant metastases
For direct detection of fluorescently tagged cells, tumor-bearing organs were resected from mice bearing orthotopic LUAD, placed
into a glass bottom dish, covered with 2% FBS in 1X phosphate-buffered saline, and imaged using a wide-field Nikon Eclipse TiE
microscope (NIS-Elements Software, Nikon). As a second approach, 4 mm tissue slices from FFPE tumor-bearing lungs were stained
with anti-GFP primary antibody and a fluorescently-labeled secondary antibody (anti-rabbit 568) and imaged with a wide-field Nikon
Eclipse TiE microscope (NIS-Elements Software, Nikon), 10x objective.
Western blotting
Cells were lysed with RIPA buffer (Cell Signaling Technology) containing protease inhibitors (Cell Signaling Technology). Cell lysates
were separated on a 4%–20% Bis-Tris gel, transferred to nitrocellulose membranes using Trans-Blot Turbo Transfer System (Bio-
Rad), and then incubated with primary antibodies and HRP-conjugated secondary antibodies (Cell Signaling Technology). Protein
bands were visualized with SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Fisher Scientific). Antibodies against
ITIH2 (Novus Biologicals, #NBP2-31750) and b-actin (Cell Signaling Technology, #4967) were purchased.
QUANTIFICATION AND STATISTICAL ANALYSIS
For MATQ data analysis, we first trimmed the unique molecular identifiers (UMI) sequence using seqtk (Shen et al., 2016). STAR (Do-
bin et al., 2013) was used to map the trimmed reads to the transcriptome. We annotated the mapped reads using HT-seq with gen-
ecode GRCm38 as a reference.We then parsed the reads annotation to the untrimmed reads and counted the gene expression using
UMI. The expression level of every gene was then normalized to the total UMI numbers of the sample. To identify non-CAFs cells, we
performed first PCA and clustering analysis by using all cells as an explorative analysis. A small proportion of cells (n = 32) were
spreading out on the PCA plot and most of them were outliers. To investigate the underlying source of these outliers, we performed
PCA analysis on these 32 cells and found that these cells are separated into three branches on the PCA. By looking into the genes on
PC1 and PC2, we identified several cell lineage markers including epithelial markers (Cdh1, Krt7, Krt18, Krt19) and hematopoietic
lineage markers (Laptm5, Hoxa10) expressed in these 32 cells. Additionally, we checked the expression of three markers (Cdh1,
Hoxa10, Laptm5) across all cells. The cells with the highest expression level of eachmarker were the outlier cells. These observations
suggested these outlier cells were potentially non-CAFs. Principal component analysis and clustering analysis were performed by
using ‘Seurat’’ R package. Genes differentially expressed between tCAF clusters were identified by using ‘limma-trend’ function
in ‘limma’ R package.
For bulk-cell RNA sequencing ofmono-cultured and co-cultured tCAFs, STAR (Dobin et al., 2013) was used tomap the reads to the
transcriptome. Reads annotation was performed using HT-seq with genecode GRCm38 as a reference. Reads normalization was
performed using EdgeR (Robinson et al., 2010). To identify significantly enriched pathways and functional hallmarks, gene set enrich-
ment analyses were performed using GSEA 4.0.3 (Subramanian et al., 2005). Gene set shuffling was used for all bulk data. For differ-
entially expressed gene analyses, EdgeR was used for tCAFs isolated from multicellular aggregates and limma-trend was used for
tCAFs co-cultured with LUAD cells in Boyden chambers.
To determine whether tCAFs were distinguishable based on gene expression signatures they acquire in co-culture with highly or
poorly metastatic LUAD cells, we first performed differential expression analyses on bulk RNA sequencing data from tCAFs co-
cultured with highly or poorly metastatic LUAD cells. The genes with FDR < 0.05 were selected for expression signatures of each
condition. We calculated the average gene expression Z-score of each signature in each tCAF analyzed by single-cell RNA
sequencing. The Z-scores were compared between clusters 1 and 2 by Student’s t test.
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Supplementary Figure 1
Figure S1. Single-cell RNA sequencing quality controls. Related to Figure 1. (A, B) PCA plots
depict batch #1 and #2 (A) and Unique Marker Identifier (UMI) numbers in each cell (B).
Supplementary Figure 2
Multicellular aggregates











































Figure S2. LUAD cells at either end of the EMT spectrum shape tCAF heterogeneity. Related
to Figure 2. (A) GSEA of upregulated genes in tCAFs that were mono-cultured (mono-) or co-
cultured with 344SQ cells (co-344SQ) or 393P cells (co-393P) in multicellular aggregates. n=
3 biological replicates per condition. (B) GSEA of upregulated genes in tCAFs that were co-
cultured with 344SQ cells (co-344SQ) or 393P cells (co-393P) in Boyden Chambers. NES
represented by bar length. FDR values color-coded. n= 5 biological replicates per condition.








Figure S3. Relative densities of tCAFs treated for indicated time periods with 20µM GM6001
(red) or vehicle dimethylsulfoxide (blue) determined by WST-1 assay. Related to Figure 4.








Figure S4. Identification of ZEB1-driven secreted factors. Related to Figure 6. (A) Heat map
depiction of selected secreted factors identified by liquid chromatography-mass spectrometry
analysis of conditioned medium samples from multicellular aggregates containing mono-
cultured cells (left heat map) or co-cultured cells (right heat map). All proteins depicted had a
P value < 0.05 (t-test). n=3 biological replicates per condition. (B) Relative levels of selected
secreted factors identified by bulk-cell RNA sequencing (Tan et al., 2018). Values expressed
as a ratio (393P_ZEB1/393P_vector). Log2FC: Log2 of fold change. n=3 biological replicates
per condition
